STAT3 and hepatocellular carcinoma: Micro-146a, an important downregulator of immune activity, exerts a negative effect on tumor development in HCC cells by promoting the expression of STAT3 activation-associated cytokines, like TGF-β, IL-17, VEGF, and I IFN, leading to HCC-induced NK cell dysfunction [79].